EVALUATION OF IOWA CANCER REGISTRY DATA LINKAGE WITH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) CANCERLINQ. POP 9/10/19 - 9/9/20.

监测、流行病学和最终结果(SEER)计划是主要的癌症之一 世界监测方案包括以人口为基础的癌症登记，包括 36%的美国总人口每年报告超过50万例癌症病例。爱荷华州 癌症登记处自1973年以来一直是SEER计划的成员。 ASCO CancerLinQ是一个为肿瘤学家提供强大的质量监控系统的计划 收集和分析所有患者就诊的数据，以提供尽可能高的质量 对病人的护理。CancerLinQ的最终目标是支持癌症中的关键利益相关者 社区包括患者、提供者、研究人员和政府。 爱荷华州癌症登记处和爱荷华州CancerLinQ诊所之间的数据交换 集水区建立了一个数据管道，以捕获记录在 电子健康记录。该试点旨在探索将索赔作为一种形式的 用于癌症监测的详细、结构化的数据。理想情况下，索赔数据将增强 SEER注册表，以捕获与癌症相关的数据，并促进医疗保健提供者遵守 法律规定的公共卫生报告要求。索赔数据也可以支持 开发可用作对供应商的反馈的质量指标。

The Surveillance, Epidemiology, and End Results (SEER) Program is one of the premier cancer surveillance programs in the world comprised of population-based cancer registries covering 36% of the total US population reporting on over 500,000 cancer cases annually. The Iowa Cancer Registry has been a member of the SEER program since 1973. ASCO CancerLinQ is a program created to give oncologists a robust quality monitoring system that collects and analyzes data from all patient encounters to deliver the highest possible quality of care to patients. The ultimate goal of CancerLinQ is to support key stakeholders in the cancer community including patients, providers, researchers, and governments. A data exchange between the Iowa Cancer Registry and CancerLinQ practices in the Iowa catchment area established a data pipeline to capture discrete data elements recorded within electronic health records. This pilot was designed to explore the use of claims as a form of detailed, structured data for cancer surveillance. Ideally, claims data would enhance the ability of SEER registries to capture cancer related data and facilitate healthcare provider compliance with legally mandated public health reporting requirements. Claims data could also support development of quality metrics that could be used as feedback to the providers.